Search

everythinglearnresearchcommunity

for

Search:↓

Chronic scalp lesions with crusts and pus that heal with strong topical steroids suggest Erosive Pustular Dermatosis, confirmed by biopsy showing specific immune cells.

Chronic scalp lesions with crusts and pus indicate Erosive Pustular Dermatosis, which is confirmed by biopsy and effectively treated with strong topical steroids.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

The document suggests a possible link between hair loss and thyroid cancer, but doesn't provide definite proof.

PRP therapy may improve skin and hair conditions, but more research with standard methods is needed.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Ashwagandha may help with skin and hair issues, but more research is needed.

Intralesional steroid therapy is useful for treating various skin conditions.

The combined therapy effectively treats androgenetic alopecia.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Hyperbaric oxygen therapy may improve hair and scalp health.

PRP shows promise for hair restoration with mild side effects, but more research is needed for clear guidelines.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Micro-needle therapy with mesotherapy may improve hair growth in men with alopecia.

Inhibiting ODC can prevent UV-induced skin cancer.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Platelet-rich plasma therapy could be an effective treatment for melasma with minimal side effects.

Vitamin C and E may help with certain skin and hair conditions, but more research is needed to confirm their effectiveness.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Membership in a self-help organization is linked to being better informed and having a higher education, but it doesn't clearly affect disease outcomes.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Alpha-blockers are recommended first for recent CP/CPPS, while antimicrobials are not advised for long-term cases.

No treatment reliably changes Alopecia Areata's course; reassurance and possibly a wig are recommended.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.